Product Code: GVR-4-68040-486-7
Endoscope Sterilization Market Trends:
The global endoscope sterilization market size was estimated at USD 1.20 billion in 2024 and is projected to grow at a CAGR of 9.64% from 2025 to 2030. This growth can be attributed to the increasing volume of surgical procedures conducted annually, which contributes to a rise in healthcare-associated infections (HAIs) associated with endoscopes. The data published by the ASP International GmbH indicates that between January 2017 and February 2021, the FDA obtained 450 medical device reports related to patient infections or contaminations associated with urological endoscopes in the U.S., including three deaths caused by subsequent bacterial infections. As a result, Karl Storz temporarily recalled over 24 models of urological endoscopes, recommending sterilization procedures outlined only in the Instructions for Use due to concerns that chemical disinfection was insufficient for adequate decontamination. Such incidents of inadequate disinfection are expected to drive demand for low-temperature sterilization for endoscopes in the coming years.
The convergence of endoscopy and robotics has revolutionized surgical possibilities, providing improved visualization, unparalleled precision, and better patient outcomes. For instance, the endoscopic surgical system from Virtuoso has two needle-sized manipulators that are robotically controlled and operate from the tip of an endoscope to bring the stability and precision of robot-assisted surgery to rigid endoscopy. Moreover, increasing numbers of successful clinical trials are expected to boost product approvals. In January 2023, Agilis Robotics, a prominent developer of flexible robotic instruments, successfully completed the second round of live animal testing with its proprietary robot for endoscopic surgery. The test results were satisfactory and demonstrated promising outcomes for the efficacy, accuracy, and safety of the firm's medical robotic system. Thus, increasing the integration of robotics in endoscopic surgery will lead to a rise in the number of procedures, thereby driving market growth.
Growing investments and funding for developing sterilization devices for endoscopes are expected to drive segment growth in the coming years. For instance, in 2020, Brighton Development secured approximately USD 0.99 million for Phase 2 of their project aimed at generating the necessary backup data to meet FDA requirements for commercializing the inside-out sterilization method. Once approved by the FDA, this technique can offer a cost-effective low-temperature sterilization solution suitable for plastic endoscopic devices that cannot be autoclaved due to the risk of melting plastic components. As a result, increasing investments in such initiatives are likely to bolster market growth throughout the forecast period.
In addition, the increasing prevalence of chronic diseases and the aging population further contribute to market growth. For instance, according to the data published by Statistics Sweden in May 2022, 8% of the Swedish population is anticipated to be 80 years or older by 2040, compared to 5% in 2022. Moreover, the WHO estimates that the number of individuals aged 80 years or older worldwide will triple within 30 years, i.e., from 2020 to 2050, to reach 426 million.
The increasing launch of novel products by industry participants is anticipated to propel the market growth. For instance, in May 2023, Ahlstrom launched the next-generation simultaneous sterilization wrap, Reliance Fusion, which would enhance the efficiency of sterilizing surgical equipment trays at hospitals. Such novel product launches by industry players are expected to drive market growth in the coming years.
Global Endoscope Sterilization Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global endoscope sterilization market report based on the product, type, device type, and region:
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Sterilizers
- Ethylene oxide sterilizers
- Hydrogen peroxide sterilizers
- Others
- Liquid Chemical Sterilization Systems
- Automated Endoscope Reprocessors (AERs)
- Type Outlook (Revenue, USD Million, 2018 - 2030)
- Flexible Endoscopes
- Single-channel Flexible Endoscopes
- Dual-channel Flexible Endoscopes
- Triple-channel Flexible Endoscopes
- Rigid Endoscopes
- Single-channel Rigid Endoscopes
- Dual-channel Rigid Endoscopes
- Device Type Outlook (Revenue, USD Million, 2018 - 2030)
- Colonoscopes
- Bronchoscopes
- Duodenoscopes
- Others
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Norway
- Denmark
- Sweden
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Content
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Type
- 1.2.3. Device Type
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary Types
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Types
- 1.9. List of Primary Types
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
Chapter 3. Endoscope sterilization Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising prevalence of HAIs
- 3.2.1.2. Increasing demand for minimally invasive procedures
- 3.2.1.3. Advances in endoscope technology
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Complex regulatory framework
- 3.2.2.2. High cost associated with advanced sterilization technologies
- 3.3. Endoscope sterilization Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
Chapter 4. Endoscope Sterilization Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
- 4.1. Endoscope Sterilization Market: Product Outlook and Key Takeaways
- 4.2. Endoscope Sterilization Market: Product Movement Analysis
- 4.3. Endoscope Sterilization Market Estimates & Forecast, by Product (USD Million)
- 4.4. Sterilizers
- 4.4.1. Sterilizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Ethylene oxide sterilizers
- 4.4.2.1. Ethylene Oxide Sterilizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Hydrogen Peroxide Sterilizers
- 4.4.3.1. Hydrogen Peroxide Sterilizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.4. Others
- 4.4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Liquid Chemical Sterilization Systems
- 4.5.1. Liquid Chemical Sterilization Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Automated Endoscope Reprocessors (AERs)
- 4.6.1. Automated Endoscope Reprocessors (AERs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Endoscope sterilization Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
- 5.1. Endoscope sterilization Market: Type Outlook and Key Takeaways
- 5.2. Endoscope sterilization Market: Type Movement Analysis
- 5.3. Endoscope sterilization Market Estimates & Forecast, by Type (USD Million)
- 5.4. Flexible Endoscopes
- 5.4.1. Flexible Endoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.2. Single-channel Flexible Endoscopes
- 5.4.2.1. Single-channel Flexible Endoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.3. Dual-channel Flexible Endoscopes
- 5.4.3.1. Dual-channel Flexible Endoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.4. Triple-channel Flexible Endoscopes
- 5.4.4.1. Triple-channel Flexible Endoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Rigid Endoscopes
- 5.5.1. Rigid Endoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.2. Single-channel Rigid Endoscopes
- 5.5.2.1. Single-channel Rigid Endoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.3. Dual-channel Rigid Endoscopes
- 5.5.3.1. Dual-channel Rigid Endoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Endoscope sterilization Market - Segment Analysis, by Device Type, 2018 - 2030 (USD Million)
- 6.1. Endoscope sterilization Market: Device Type Outlook and Key Takeaways
- 6.2. Endoscope sterilization Market: Device Type Movement Analysis
- 6.3. Endoscope sterilization Market Estimates & Forecast, by Type (USD Million)
- 6.4. Colonoscopes
- 6.4.1. Colonoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Bronchoscopes
- 6.5.1. Bronchoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Duodenoscopes
- 6.6.1. Duodenoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Others
Chapter 7. Endoscope sterilization Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
- 7.3. North America
- 7.3.1. U.S.
- 7.3.1.1. Key country dynamics
- 7.3.1.2. Regulatory framework/ reimbursement structure
- 7.3.1.3. Competitive scenario
- 7.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.3.2. Canada
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Regulatory framework/ reimbursement structure
- 7.3.2.3. Competitive scenario
- 7.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.3.3. Mexico
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Regulatory framework/ reimbursement structure
- 7.3.3.3. Competitive scenario
- 7.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Regulatory framework/ reimbursement structure
- 7.4.1.3. Competitive scenario
- 7.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework/ reimbursement structure
- 7.4.2.3. Competitive scenario
- 7.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.3. France
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework/ reimbursement structure
- 7.4.3.3. Competitive scenario
- 7.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.4. Italy
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework/ reimbursement structure
- 7.4.4.3. Competitive scenario
- 7.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.5. Spain
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Regulatory framework/ reimbursement structure
- 7.4.5.3. Competitive scenario
- 7.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.6. Norway
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Regulatory framework/ reimbursement structure
- 7.4.6.3. Competitive scenario
- 7.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Regulatory framework/ reimbursement structure
- 7.4.7.3. Competitive scenario
- 7.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Regulatory framework/ reimbursement structure
- 7.4.8.3. Competitive scenario
- 7.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework/ reimbursement structure
- 7.5.1.3. Competitive scenario
- 7.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.2. China
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.3. India
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework/ reimbursement structure
- 7.5.3.3. Competitive scenario
- 7.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.4. Australia
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework/ reimbursement structure
- 7.5.4.3. Competitive scenario
- 7.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework/ reimbursement structure
- 7.5.5.3. Competitive scenario
- 7.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework/ reimbursement structure
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework/ reimbursement structure
- 7.6.1.3. Competitive scenario
- 7.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.2. Argentina
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7. MEA
- 7.7.1. South Africa
- 7.7.1.2. Key country dynamics
- 7.7.1.3. Regulatory framework/ reimbursement structure
- 7.7.1.4. Competitive scenario
- 7.7.1.5. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ reimbursement structure
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.3. UAE
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework/ reimbursement structure
- 7.7.3.3. Competitive scenario
- 7.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.4. Kuwait
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework/ reimbursement structure
- 7.7.4.3. Competitive scenario
- 7.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Recent Developments & Impact Analysis by Key Market Participants
- 8.3. Company Market Share Analysis, 2024
- 8.4. Key Company Profiles
- 8.4.1. Andersen Sterilizers
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. ASP (Fortive Corporation)
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Getinge
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Steelco S.p.A.
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. AURORA
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Nanosonics
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. H.W.Andersen Products Ltd.
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. Ecolab
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Tuttnauer
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Stryker
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives